We previously showed in a cohort of 299 diabetic patients with PAD that baseline OPG, TNF-α, IL-6, and CRP levels were associated with adverse cardiovascular outcomes after LER [17]. The gene discussed is TNFRSF11B; the disease is peripheral arterial disease.